Total Reports
8
Low report volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Katahdin (Sheep) in the FDA Center for Veterinary Medicine openFDA extract. Browse sheep breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Katahdin, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Katahdin ranks #449 of 510 by total reports (8). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Katahdin has 8 reports now versus 8 in that prior snapshot: 0 the same number of (0.0%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Katahdin changesTotal Reports
8
Low report volume
Deaths Reported
3
of 8 reports
Death-coded share of reports
37.5%
37.5% death-coded
Avg Age at Report
0.8 yr
32.4 kg avg weight
37.5% of 8 katahdin reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2011 | 1 | |
| 2013 | 3 | |
| 2014 | 1 | |
| 2015 | 2 | |
| 2023 | 1 | |
Signature read: 8 reports place Katahdin in the lower third of breed filing volume (#454 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Katahdin sits at #454 of 510 by report volume among all breeds and #6 of 9 among sheep breeds, with 8 reports and 3 (37.5%) death-coded. Mean age at report: 0.8 years, average weight 32.4 kg (71.4 lbs).
Top reported signs: Lack of efficacy (endoparasite) - tapeworm (3), INEFFECTIVE, STOMACH WORM NOS (2), Death (2). Most-referenced drug: Albendazole (7 reports), followed by Ivermectin (2).
Outcome coding on 10 status-recorded reports is dominated by Outcome Unknown (70.0%). Annual submissions ranged 1-2,023 across 5 years on file.
Showing 6 of 8 sheep breeds in our dataset, ranked by closest report volume.
Sparse-volume peer sets for Katahdin drawn from openFDA outside the Sheep family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds by reported average weight (32.4 kg here).
What to do with this sheep
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →